Chemical Compound

5ss-Ergosta-2,24-dien-26-oic acid, 5,6ss-epoxy-4ss,22,27-trihydroxy-1-oxo-, d-lactone, (20S,22R)- (8CI); Withaferin A (7CI); 5,6-Epoxy-5H-cyclopenta[a]phenanthrene, ergosta-2,24-dien-26-oic acid deriv.; NSC 101088; NSC 273757; Withaferine; Withaferine A; (4ss,5ss,6ss,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid d-lactone

CAS Registry Number 5119-48-2
返回搜索 申请报价
5ss-Ergosta-2,24-dien-26-oic acid, 5,6ss-epoxy-4ss,22,27-trihydroxy-1-oxo-, d-lactone, (20S,22R)- (8CI); Withaferin A (7CI); 5,6-Epoxy-5H-cyclopenta[a]phenanthrene, ergosta-2,24-dien-26-oic acid deriv.; NSC 101088; NSC 273757; Withaferine; Withaferine A; (4ss,5ss,6ss,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid d-lactone 结构式
Primary record

5ss-Ergosta-2,24-dien-26-oic acid, 5,6ss-epoxy-4ss,22,27-trihydroxy-1-oxo-, d-lactone, (20S,22R)- (8CI); Withaferin A (7CI); 5,6-Epoxy-5H-cyclopenta[a]phenanthrene, ergosta-2,24-dien-26-oic acid deriv.; NSC 101088; NSC 273757; Withaferine; Withaferine A; (4ss,5ss,6ss,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid d-lactone

库存
1,484 克
纯度
98.8 %
CAS
5119-48-2

化合物标识与属性

CAS
5119-48-2
PubChem CID
265237
SMILES
CC1=C(C(=O)O[C@H](C1)[C@@H](C)[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3C[C@@H]5[C@]6([C@@]4(C(=O)C=C[C@@H]6O)C)O5)C)CO
Canonical SMILES
CC1=C(CO)C(=O)O[C@@H]([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)C1

名称与同义词

  • Withaferin A
  • Withaferine A
  • Ashwagandha
  • 5119-48-2
  • Withaferine
  • Withaferin-A
  • BUPRANOLOL
  • WITHAFERINA
  • L6DO3QW4K5
  • NSC-101088
  • UNII-L6DO3QW4K5
  • NSC 273757
  • Withaferin A (Standard)
  • RefChem:934222
  • CHEBI:69120
  • D0V3PN
  • WITHAFERIN A [MI]
  • AC1L6DJ0
  • DTXSID10965459
  • CHEMBL517080
  • MFCD10687098
  • C28H38O6
  • MLS006010687
  • NSC-273757
  • SCHEMBL157208
  • NSC101088
  • orb1301583
  • WITHAFERIN DERIV JPR, IOWA U. COMPOUND
  • NSC 101088
  • GTPL13097
  • HY-N2065R
  • BRN 1335150
  • Withaferin A, analytical standard
  • DBRXOUCRJQVYJQ-CKNDUULBSA-N
  • DTXCID901393128
  • Withaferin A, >=95% (HPLC)
  • HY-N2065
  • Withaferin A, 99% - 1MG 1mg
  • ZINC8234189
  • AR-1G1030
  • BBF-04067
  • BDBM50599323
  • CID265237
  • EX-A12011
  • NSC273757
  • s8587
  • AKOS040758787
  • C28-H38-O6
  • CID:265237
  • CS-O-14315
  • EBC-460096
  • FW32226
  • J8.811K
  • NCGC00180796-02
  • NCGC00180796-05
  • AS-77575
  • LS-64535
  • NCI60_000031
  • SMR004701668
  • SY075940
  • SID:135653688
  • B7199
  • CS-0018562
  • Withaferin A 100 microg/mL in Acetonitrile
  • 5-19-06-00604 (Beilstein Handbook Reference)
  • 4beta,27-dihydroxy-1-oxo-5beta,6beta-epoxywitha-2,24-dienolide
  • C08841
  • A871350
  • C009684
  • HSF-1 inhibitor (melanoma), University of Kansas
  • (1S,2R,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-15-[(1S)-1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one
  • 2,3,3-trimethyl-2H-benzo[g]benzofuran-4,5-dione
  • A1-06845
  • Q6606395
  • BRD-K88378636-001-01-0
  • 4b,27-dihydroxy-1-oxo-5b,6b-epoxywitha-2,24-dienolide
  • 5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dienoic acid delta-lactone
  • 5,6-Epoxy-4,27-dihydroxy-1-oxowitha-2 ,24-dienolide
  • 5,6-Epoxy-4,27-dihydroxy-1-oxowitha-2,24-dienolide
  • (4beta,5beta,6beta,22R)-4,27-dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione
  • (6S,7R,9R)-6-Hydroxy-15-[(2R,3R)-3-hydroxy-4-(4-methyl-5-oxo-2H-furan-3-yl)butan-2-yl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one
  • Heat shock factor 1 inhibitor (melanoma), University of Kansas
  • WITHAFERIN A (CONSTITUENT OF ASHWAGANDHA ROOT) [DSC]
  • (4 beta,5 beta,6 beta,22R)-5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta- 2,24-dien-26-oic acid, delta-lactone
  • (4beta,5beta,6beta,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic acid, delta-lactone
  • 5-beta-Ergosta-2,24-dien-26-oic acid, 5,6-beta-epoxy-4-beta,22,27-trihydroxy-1-oxo-, delta-lactone, (20S,22R)-
  • 5beta-Ergosta-2,24-dien-26-oic acid, 5,6beta-epoxy-4beta,22,27-trihydroxy-1-oxo-, delta-lactone, (20S,22R)-
  • Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, gamma-lactone, (4bta,5beta,6beta,22R)-
  • (22R)-4beta,27-Dihydroxy-5beta,6beta-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione
  • (4?,5?,6?,22R)-4,27-Dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione
  • WLN: T3 F5 E666 1A R AXO OV PU CH&TTTTJ J1 N1 RQ IY1&- FT6OV CUTJ C1Q D1
  • (1S,2R,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-15-((1S)-1-((2R)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl)-2,16-dimethyl-8-oxapentacyclo(9.7.0.02,7.07,9.012,16)octadec-4-en-3-one
  • (1S,2R,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-15-[(1S)-1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0^{2,7}.0^{7,9}.0^{12,16}]octadec-4-en-3-one
  • (1S,2R,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-15-[(1S)-1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one
  • (20S)-4beta-Hydroxy-20-[4-methyl-5-(hydroxymethyl)-6-oxo-3,6-dihydro-2H-pyran-2beta-yl]-5,6beta-epoxy-5beta-pregna-2-ene-1-one
  • (20S)-4beta-Hydroxy-5beta,6beta-epoxy-20-[(R)-2,3-dihydro-4-methyl-5-(hydroxymethyl)-6-oxo-6H-pyran-2-yl]pregna-2-ene-1-one
  • (20S,22R)-5,6|A-Epoxy-4|A,22,27-trihydroxy-1-oxo-5|A-ergosta-2,24-dien-26-oic Acid |A-Lactone
  • (22R)-5,6beta-Epoxy-4beta,22,27-trihydroxy-1-oxo-5beta-ergosta-2,24-dien-26-oic acid delta-lactone
  • (4 beta,5 beta,6 beta,22R)-5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic acid, delta-lactone
  • (4-beta,5-beta,6-beta,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic acid delta-lactone
  • (4.BETA.,5.BETA.,6.BETA.,22R)-4,27-DIHYDROXY-5,6:22,26-DIEPOXYERGOSTA-2,24-DIENE-1,26-DIONE
  • (4|A,5|A,6|A,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic Acid |A-Lactone
  • (4b,5b,6b,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2 ,24-dien-26-oic acid d-lactone
  • (4S,4aR,5aR,6aS,6bS,9R,9aS,11aS,11bR)-4-hydroxy-9-((S)-1-((R)-5-(hydroxymethyl)-4-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-9a,11b-dimethyl-5a,6,6a,6b,7,8,9,9a,10,11,11a,11b-dodecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-1(4H)-one
  • 4|A,5|A,6|A,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid |A-lactone
  • 5.beta.-Ergosta-2, 5,6.beta.-epoxy-4.beta.,22,27-trihydroxy-1-oxo-, .delta.-lactone, (20S,22R)-
  • 5.beta.-Ergosta-2,24-dien-26-oic acid, 5,6.beta.-epoxy-4.beta.,22,27-trihydroxy-1-oxo-, .delta.-lactone, (20S,22R)-
  • 5?-Ergosta-2,24-dien-26-oic acid, 5,6?-epoxy-4?,22,27-trihydroxy-1-oxo-, ?-lactone, (20S,22R)- (8CI); Withaferin A (7CI); 5,6-Epoxy-5H-cyclopenta[a]phenanthrene, ergosta-2,24-dien-26-oic acid deriv.; NSC 101088; NSC 273757; Withaferine; Withaferine A; (4?,5?,6?,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid ?-lactone
  • 51572-98-6
  • 5ss-Ergosta-2,24-dien-26-oic acid, 5,6ss-epoxy-4ss,22,27-trihydroxy-1-oxo-, d-lactone, (20S,22R)- (8CI); Withaferin A (7CI); 5,6-Epoxy-5H-cyclopenta[a]phenanthrene, ergosta-2,24-dien-26-oic acid deriv.; NSC 101088; NSC 273757; Withaferine; Withaferine A; (4ss,5ss,6ss,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid d-lactone
  • Ergosta-2, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,22R)-
  • Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,22,27-trihydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,22R)-
  • NCGC00180796-02_C28H38O6_(4beta,5beta,6beta,22R)-4,27-Dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione
  • WFA